chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Pain in extremity, Wrong technique in product usage process
Clinical narrative: Did not squeeze the muscle before administering the vaccine; pain in the arm /a lot of pain in upper quad of my arm; Cannot lift arm over head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm /a lot of pain in upper quad of my arm), HYPOKINESIA (Cannot lift arm over head) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Did not squeeze the muscle before administering the vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003421A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Did not squeeze the muscle before administering the vaccine). In March 2021, the patient experienced PAIN IN EXTREMITY (pain in the arm /a lot of pain in upper quad of my arm) and HYPOKINESIA (Cannot lift arm over head). On 15-Mar-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Did not squeeze the muscle before administering the vaccine) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (pain in the arm /a lot of pain in upper quad of my arm) and HYPOKINESIA (Cannot lift arm over head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Malaise, Myalgia
Clinical narrative: Sick as dogs; Severe Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Sick as dogs), CHILLS (Severe Chills) and MYALGIA (Body aches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 031M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included OMEPRAZOLE from 10-May-1995 to an unknown date for an unknown indication.   On 12-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced MALAISE (Sick as dogs), CHILLS (Severe Chills) and MYALGIA (Body aches). On 15-Mar-2021, CHILLS (Severe Chills) and MYALGIA (Body aches) had resolved. At the time of the report, MALAISE (Sick as dogs) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable No treatment for the events was reported.   This case was linked to MOD-2021-116538 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: event were updated On 07-Jul-2021: No new information was provided.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nasopharyngitis, Sleep disorder, Vertigo
Clinical narrative: Had symptoms of a cold; At night he slept in stages; Vertigo; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Had symptoms of a cold), SLEEP DISORDER (At night he slept in stages), VERTIGO (Vertigo) and CHILLS (Chills) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced NASOPHARYNGITIS (Had symptoms of a cold), SLEEP DISORDER (At night he slept in stages), VERTIGO (Vertigo) and CHILLS (Chills). At the time of the report, NASOPHARYNGITIS (Had symptoms of a cold), SLEEP DISORDER (At night he slept in stages), VERTIGO (Vertigo) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Body temperature: abnormal (High) 98.3 -high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment history was not reported. The concomitant medication was not reported. Patient's all events had been resolved but still feeled there was something wrong but not vertigo anymore. Patient did not feel normal and was unable to explain. Overall patient feeled a lot batter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Significant follow-up Outcome of the events updated in follow up report.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site erythema, Vaccination site swelling
Clinical narrative: red rash on bilateral arms; injection site redness and swelling; injection site redness and swelling; This spontaneous case was reported by a nurse and describes the occurrence of RASH ERYTHEMATOUS (red rash on bilateral arms), VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021 at 6:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021 at 4:30 AM, the patient experienced RASH ERYTHEMATOUS (red rash on bilateral arms), VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling). At the time of the report, RASH ERYTHEMATOUS (red rash on bilateral arms), VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered RASH ERYTHEMATOUS (red rash on bilateral arms) to have an unknown relationship. No further causality assessments were provided for VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling).    No concomitant medication was reported.  Treatment information not provided.    Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up received on 07-May-2021 contains no significant information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Syringe issue
Clinical narrative: Needle Hub Broke; liquid  Dripped down Arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SYRINGE ISSUE (Needle Hub Broke) and ACCIDENTAL UNDERDOSE (liquid  Dripped down Arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. BNT162B2) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced SYRINGE ISSUE (Needle Hub Broke) and ACCIDENTAL UNDERDOSE (liquid  Dripped down Arm). On 02-Mar-2021, SYRINGE ISSUE (Needle Hub Broke) and ACCIDENTAL UNDERDOSE (liquid  Dripped down Arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatments were reported.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: bad rashes on different portions of his body/ Rash on arms, shoulders, and neck after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of RASH (bad rashes on different portions of his body/ Rash on arms, shoulders, and neck after getting the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (bad rashes on different portions of his body/ Rash on arms, shoulders, and neck after getting the vaccine). At the time of the report, RASH (bad rashes on different portions of his body/ Rash on arms, shoulders, and neck after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatments were reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Palpitations
Clinical narrative: chest still heavy; hard to breath; trouble breathing; heart racing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (trouble breathing), PALPITATIONS (heart racing), CHEST DISCOMFORT (chest still heavy ) and DYSPNOEA (hard to breath) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced DYSPNOEA (trouble breathing) and PALPITATIONS (heart racing). On 15-Mar-2021, the patient experienced CHEST DISCOMFORT (chest still heavy ). 15-Mar-2021, the patient experienced DYSPNOEA (hard to breath). At the time of the report, DYSPNOEA (trouble breathing) and PALPITATIONS (heart racing) had resolved and CHEST DISCOMFORT (chest still heavy ) and DYSPNOEA (hard to breath) outcome was unknown.            No Concomitant medications were reported. Treatment included self sleep aide (nature's garden).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Reduced facial expression
Clinical narrative: 5 min after I left I felt my face getting numb; she feels likes it getting worse, sometimes feels fine and then it will feel tight again; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (5 min after I left I felt my face getting numb) and REDUCED FACIAL EXPRESSION (she feels likes it getting worse, sometimes feels fine and then it will feel tight again) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical information history was reported.  Concomitant products included VITAMINS NOS, CALCIUM and IRON for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced HYPOAESTHESIA (5 min after I left I felt my face getting numb) and REDUCED FACIAL EXPRESSION (she feels likes it getting worse, sometimes feels fine and then it will feel tight again). At the time of the report, HYPOAESTHESIA (5 min after I left I felt my face getting numb) and REDUCED FACIAL EXPRESSION (she feels likes it getting worse, sometimes feels fine and then it will feel tight again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient concomitant medications included birth control pills.   Patient reported that pretty much whole left side of the face, upper lip, jaw, nose, eye and ear got numb. She was able to talk, eat and function for most of the part. She had not taken anything for the treatment of the numbness.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient was tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient was tested positive for COVID-19) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Patient was tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient was tested positive for COVID-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Influenza like illness, Pain
Clinical narrative: felt like a limp dishrag; flu like symptoms; achy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like a limp dishrag), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN (achy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol. Concomitant products included VITAMIN C [ASCORBIC ACID], VITAMIN D [VITAMIN D NOS], CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), ACETYLSALICYLIC ACID (BABY ASPIRIN) and DENOSUMAB (PROLIA) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced FEELING ABNORMAL (felt like a limp dishrag), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, FEELING ABNORMAL (felt like a limp dishrag), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN (achy) had resolved.            Patient's concomitant medications included unspecified  blood pressure medication, cholesterol medication and eye vitamins.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Therapeutic procedure, Ultrasound abdomen
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (The patient used to have alcohol occasionally.). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 12-Dec-2020 and the estimated date of delivery was 14-Sep-2021. On 12-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy.  On 12-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Pregnancy test: positive (Positive) Positive. On 13-Feb-2021, Therapeutic procedure: normal (normal) Noninvasive prenatal testing was done and genetic testing was normal.. On 11-Mar-2021, Ultrasound abdomen: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.  The patient gave twice live full term birth on 03-Mar-2016 and 02-Feb-2019.   The estimated date of conception was reported as 20-Dec-2020. The patient had no maternal history of subfertility and had established prenatal care. There was no complications or acute illness reported during tis pregnancy. Number of fetuses was reported as 1.   This case was linked to US-irms-MOD21-111429 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Reporter address details added; Sender's Comments:  US-irms-MOD21-111429.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Limb mass, Vaccination site erythema, Vaccination site induration
Clinical narrative: A lump on the inside of the same arm NOT at the inoculation site; Large red warm patch with an enduration of 2 X 2 inches; Large red warm patch with an enduration of 2 X 2 inches; Large red warm patch with an enduration of 2 X 2 inches; Tired; Arm hurt the first day; This spontaneous case was reported by a consumer and describes the occurrence of LIMB MASS (A lump on the inside of the same arm NOT at the inoculation site), VACCINATION SITE WARMTH (Large red warm patch with an enduration of 2 X 2 inches), INJECTION SITE PAIN (Arm hurt the first day), VACCINATION SITE INDURATION (Large red warm patch with an enduration of 2 X 2 inches) and VACCINATION SITE ERYTHEMA (Large red warm patch with an enduration of 2 X 2 inches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced INJECTION SITE PAIN (Arm hurt the first day) and FATIGUE (Tired). On 13-Mar-2021, the patient experienced LIMB MASS (A lump on the inside of the same arm NOT at the inoculation site), VACCINATION SITE WARMTH (Large red warm patch with an enduration of 2 X 2 inches), VACCINATION SITE INDURATION (Large red warm patch with an enduration of 2 X 2 inches) and VACCINATION SITE ERYTHEMA (Large red warm patch with an enduration of 2 X 2 inches). The patient was treated with DOXYCYCLINE at a dose of 100 mg twice a day. On 06-Mar-2021, INJECTION SITE PAIN (Arm hurt the first day) and FATIGUE (Tired) had resolved. At the time of the report, LIMB MASS (A lump on the inside of the same arm NOT at the inoculation site), VACCINATION SITE WARMTH (Large red warm patch with an enduration of 2 X 2 inches), VACCINATION SITE INDURATION (Large red warm patch with an enduration of 2 X 2 inches) and VACCINATION SITE ERYTHEMA (Large red warm patch with an enduration of 2 X 2 inches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: A lump on the inside of the same arm NOT at the inoculation site; Large red warm patch with an enduration of 2 X 2 inches; Large red warm patch with an enduration of 2 X 2 inches; Large red warm patch with an enduration of 2 X 2 inches; Tired; Arm hurt the first day; This spontaneous case was reported by a consumer and describes the occurrence of LIMB MASS (A lump on the inside of the same arm NOT at the inoculation site), VACCINATION SITE WARMTH (Large red warm patch with an enduration of 2 X 2 inches), INJECTION SITE PAIN (Arm hurt the first day), VACCINATION SITE INDURATION (Large red warm patch with an enduration of 2 X 2 inches) and VACCINATION SITE ERYTHEMA (Large red warm patch with an enduration of 2 X 2 inches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced INJECTION SITE PAIN (Arm hurt the first day) and FATIGUE (Tired). On 13-Mar-2021, the patient experienced LIMB MASS (A lump on the inside of the same arm NOT at the inoculation site), VACCINATION SITE WARMTH (Large red warm patch with an enduration of 2 X 2 inches), VACCINATION SITE INDURATION (Large red warm patch with an enduration of 2 X 2 inches) and VACCINATION SITE ERYTHEMA (Large red warm patch with an enduration of 2 X 2 inches). The patient was treated with DOXYCYCLINE at a dose of 100 mg twice a day. On 06-Mar-2021, INJECTION SITE PAIN (Arm hurt the first day) and FATIGUE (Tired) had resolved. At the time of the report, LIMB MASS (A lump on the inside of the same arm NOT at the inoculation site), VACCINATION SITE WARMTH (Large red warm patch with an enduration of 2 X 2 inches), VACCINATION SITE INDURATION (Large red warm patch with an enduration of 2 X 2 inches) and VACCINATION SITE ERYTHEMA (Large red warm patch with an enduration of 2 X 2 inches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Feeling hot, Headache
Clinical narrative: Arm was pink; Felt nauseas; Was really tired / fatigued; Not feeling well; Had a headache; Had a swollen arm; Felt heat rising up to her head; Felt lightheaded, like she was going to pass out; felt weird; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt lightheaded, like she was going to pass out), FEELING ABNORMAL (felt weird), PERIPHERAL SWELLING (Had a swollen arm), SKIN DISCOLOURATION (Arm was pink) and FEELING HOT (Felt heat rising up to her head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had COVID last year) in 2020.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (Felt lightheaded, like she was going to pass out), FEELING ABNORMAL (felt weird) and FEELING HOT (Felt heat rising up to her head). On 13-Mar-2021, the patient experienced PERIPHERAL SWELLING (Had a swollen arm), MALAISE (Not feeling well), HEADACHE (Had a headache) and FATIGUE (Was really tired / fatigued). On 14-Mar-2021, the patient experienced SKIN DISCOLOURATION (Arm was pink) and NAUSEA (Felt nauseas). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 12-Mar-2021, DIZZINESS (Felt lightheaded, like she was going to pass out), FEELING ABNORMAL (felt weird) and FEELING HOT (Felt heat rising up to her head) had resolved. At the time of the report, PERIPHERAL SWELLING (Had a swollen arm), SKIN DISCOLOURATION (Arm was pink), MALAISE (Not feeling well), HEADACHE (Had a headache), NAUSEA (Felt nauseas) and FATIGUE (Was really tired / fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment details included use of ice along with ibuprofen.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Peripheral swelling, Skin discolouration
Clinical narrative: Arm was pink; Felt nauseas; Was really tired / fatigued; Not feeling well; Had a headache; Had a swollen arm; Felt heat rising up to her head; Felt lightheaded, like she was going to pass out; felt weird; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt lightheaded, like she was going to pass out), FEELING ABNORMAL (felt weird), PERIPHERAL SWELLING (Had a swollen arm), SKIN DISCOLOURATION (Arm was pink) and FEELING HOT (Felt heat rising up to her head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had COVID last year) in 2020.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (Felt lightheaded, like she was going to pass out), FEELING ABNORMAL (felt weird) and FEELING HOT (Felt heat rising up to her head). On 13-Mar-2021, the patient experienced PERIPHERAL SWELLING (Had a swollen arm), MALAISE (Not feeling well), HEADACHE (Had a headache) and FATIGUE (Was really tired / fatigued). On 14-Mar-2021, the patient experienced SKIN DISCOLOURATION (Arm was pink) and NAUSEA (Felt nauseas). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 12-Mar-2021, DIZZINESS (Felt lightheaded, like she was going to pass out), FEELING ABNORMAL (felt weird) and FEELING HOT (Felt heat rising up to her head) had resolved. At the time of the report, PERIPHERAL SWELLING (Had a swollen arm), SKIN DISCOLOURATION (Arm was pink), MALAISE (Not feeling well), HEADACHE (Had a headache), NAUSEA (Felt nauseas) and FATIGUE (Was really tired / fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment details included use of ice along with ibuprofen.
Sex: F
Vaccine: COVID19
Symptoms: Hepatic enzyme increased
Clinical narrative: elevated liver enzymes; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (elevated liver enzymes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEPATIC ENZYME INCREASED (elevated liver enzymes). At the time of the report, HEPATIC ENZYME INCREASED (elevated liver enzymes) outcome was unknown.            No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Gastroenteritis viral, Pyrexia
Clinical narrative: had a stomach flu or virus that has past around the whole family; diarrhea; fever; This spontaneous case was reported by a consumer and describes the occurrence of GASTROENTERITIS VIRAL (had a stomach flu or virus that has past around the whole family), DIARRHOEA (diarrhea) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GASTROENTERITIS VIRAL (had a stomach flu or virus that has past around the whole family), DIARRHOEA (diarrhea) and PYREXIA (fever). At the time of the report, GASTROENTERITIS VIRAL (had a stomach flu or virus that has past around the whole family), DIARRHOEA (diarrhea) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasopharyngitis, Rhinorrhoea
Clinical narrative: cold; running nose during the day; stuffy nose at night; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), RHINORRHOEA (running nose during the day) and NASAL CONGESTION (stuffy nose at night) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), RHINORRHOEA (running nose during the day) and NASAL CONGESTION (stuffy nose at night). At the time of the report, NASOPHARYNGITIS (cold), RHINORRHOEA (running nose during the day) and NASAL CONGESTION (stuffy nose at night) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pruritus
Clinical narrative: sensitivity on the back; itchiness on the back; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (sensitivity on the back) and PRURITUS (itchiness on the back) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (sensitivity on the back) and PRURITUS (itchiness on the back). At the time of the report, MUSCULOSKELETAL DISCOMFORT (sensitivity on the back) and PRURITUS (itchiness on the back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 91.0
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Asthenopia, Feeling abnormal, Headache, Irritability
Clinical narrative: arm sore; bothersome for 8 to 9 hours; 5 days later weak; Couldn't keep eyes open; feel nasty; Slept; vomitted; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), IRRITABILITY (bothersome for 8 to 9 hours), ASTHENIA (5 days later weak), ASTHENOPIA (Couldn't keep eyes open) and FEELING ABNORMAL (feel nasty) in a 91-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm sore), IRRITABILITY (bothersome for 8 to 9 hours), ASTHENIA (5 days later weak), ASTHENOPIA (Couldn't keep eyes open), FEELING ABNORMAL (feel nasty), SOMNOLENCE (Slept), VOMITING (vomitted) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm sore), IRRITABILITY (bothersome for 8 to 9 hours), ASTHENIA (5 days later weak), ASTHENOPIA (Couldn't keep eyes open), FEELING ABNORMAL (feel nasty), SOMNOLENCE (Slept), VOMITING (vomitted) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 91.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Somnolence, Vomiting
Clinical narrative: arm sore; bothersome for 8 to 9 hours; 5 days later weak; Couldn't keep eyes open; feel nasty; Slept; vomitted; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), IRRITABILITY (bothersome for 8 to 9 hours), ASTHENIA (5 days later weak), ASTHENOPIA (Couldn't keep eyes open) and FEELING ABNORMAL (feel nasty) in a 91-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm sore), IRRITABILITY (bothersome for 8 to 9 hours), ASTHENIA (5 days later weak), ASTHENOPIA (Couldn't keep eyes open), FEELING ABNORMAL (feel nasty), SOMNOLENCE (Slept), VOMITING (vomitted) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm sore), IRRITABILITY (bothersome for 8 to 9 hours), ASTHENIA (5 days later weak), ASTHENOPIA (Couldn't keep eyes open), FEELING ABNORMAL (feel nasty), SOMNOLENCE (Slept), VOMITING (vomitted) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warm to the touch; kind of red; injection site started itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (injection site started itching) and VACCINATION SITE ERYTHEMA (kind of red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 011M20A) for COVID-19 vaccination.     The patient's past medical history included Thyroidectomy (Thyroid surgery with half of thyroid removed). Concurrent medical conditions included Hypertension.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (injection site started itching). On 16-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch) and VACCINATION SITE ERYTHEMA (kind of red). At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (injection site started itching) and VACCINATION SITE ERYTHEMA (kind of red) outcome was unknown.            Patient's concomitant medications included unspecified medicines for high blood pressure and thyroid.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: Muscle Pain focusing in the pelvic bone; Joint Pain focusing in the pelvic bone; Tiredness, Exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness, Exhaustion), MYALGIA (Muscle Pain focusing in the pelvic bone) and ARTHRALGIA (Joint Pain focusing in the pelvic bone) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical information history was reported.  Concomitant products included BIMATOPROST (LUMIGAN) and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FATIGUE (Tiredness, Exhaustion). On 09-Mar-2021, the patient experienced MYALGIA (Muscle Pain focusing in the pelvic bone) and ARTHRALGIA (Joint Pain focusing in the pelvic bone). At the time of the report, FATIGUE (Tiredness, Exhaustion), MYALGIA (Muscle Pain focusing in the pelvic bone) and ARTHRALGIA (Joint Pain focusing in the pelvic bone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient used unspecified home remedies to treat the events.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Pain in extremity, Pyrexia
Clinical narrative: fever; feels sick; arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ILLNESS (feels sick) and PAIN IN EXTREMITY (arm hurts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PYREXIA (fever), ILLNESS (feels sick) and PAIN IN EXTREMITY (arm hurts). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), ILLNESS (feels sick) and PAIN IN EXTREMITY (arm hurts) outcome was unknown.            No concomitant medications were provided by the reporter.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain in extremity
Clinical narrative: Got really lightheaded and dizzy; Nauseated; Arm was sore like someone had punched him in his shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore like someone had punched him in his shoulder), DIZZINESS (Got really lightheaded and dizzy) and NAUSEA (Nauseated) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included FINASTERIDE, LISINOPRIL and TAMSULOSIN for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore like someone had punched him in his shoulder). On 14-Mar-2021, the patient experienced DIZZINESS (Got really lightheaded and dizzy) and NAUSEA (Nauseated). At the time of the report, PAIN IN EXTREMITY (Arm was sore like someone had punched him in his shoulder), DIZZINESS (Got really lightheaded and dizzy) and NAUSEA (Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient felt lightheaded when he laid down and got up. Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia
Clinical narrative: fatigue; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches) and FATIGUE (fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced CHILLS (chills) and MYALGIA (body aches). On 15-Mar-2021, the patient experienced FATIGUE (fatigue). On 16-Mar-2021, CHILLS (chills), MYALGIA (body aches) and FATIGUE (fatigue) had resolved. Not Provided          No concomitant medications were reported.  Patient did not took any treatment for the events.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Fatique; Headache; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (Headache) and FATIGUE (Fatique) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (Headache). On 12-Mar-2021, the patient experienced FATIGUE (Fatique). On 11-Mar-2021, HEADACHE (Headache) had resolved. On 14-Mar-2021, FATIGUE (Fatique) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided.  No treatment was given for the symptoms.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: temperature went up just a little bit but not a lot; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature went up just a little bit but not a lot) and CHILLS (chills) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (temperature went up just a little bit but not a lot) and CHILLS (chills). At the time of the report, PYREXIA (temperature went up just a little bit but not a lot) had resolved and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) 99.5.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD21-054356 (Patient Link).   Reporter did not allow further contact
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received a dose of the Moderna Covid 19 vaccine that is past the 6 hour timeframe from being extracted from the vial.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine that is past the 6 hour timeframe from being extracted from the vial.) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021 at 2:48 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine that is past the 6 hour timeframe from being extracted from the vial.). On 15-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Received a dose of the Moderna Covid 19 vaccine that is past the 6 hour timeframe from being extracted from the vial.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No specific follow-up information recorded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: tiredness; Redness at the injection site; itching at the injection site; warm to touch at the site of the injection; swelling at the site of the injection; pain at the site of the injection; feel hard at the site of the injection; swollen lymph nodes right neck; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm to touch at the site of the injection), INJECTION SITE SWELLING (swelling at the site of the injection), INJECTION SITE PAIN (pain at the site of the injection), INJECTION SITE INDURATION (feel hard at the site of the injection) and LYMPHADENOPATHY (swollen lymph nodes right neck) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced INJECTION SITE WARMTH (warm to touch at the site of the injection), INJECTION SITE SWELLING (swelling at the site of the injection), INJECTION SITE PAIN (pain at the site of the injection), INJECTION SITE INDURATION (feel hard at the site of the injection), LYMPHADENOPATHY (swollen lymph nodes right neck), INJECTION SITE ERYTHEMA (Redness at the injection site) and INJECTION SITE PRURITUS (itching at the injection site). On an unknown date, the patient experienced FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form and IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, INJECTION SITE WARMTH (warm to touch at the site of the injection), INJECTION SITE SWELLING (swelling at the site of the injection), INJECTION SITE PAIN (pain at the site of the injection), INJECTION SITE INDURATION (feel hard at the site of the injection), INJECTION SITE ERYTHEMA (Redness at the injection site) and INJECTION SITE PRURITUS (itching at the injection site) had not resolved, LYMPHADENOPATHY (swollen lymph nodes right neck) had resolved and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient symptoms started on 12MAR2021 & gradually worsened. She took  Advil & Tylenol along with applying some ice pack which was helpful. Symptoms  are unchanged since taking the medication.